The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Travel, Accommodations, Expenses - Bayer; Celgene; Roche Pharma AG
CONKO-005: Adjuvant therapy in R0 resected pancreatic cancer patients with gemcitabine plus erlotinib versus gemcitabine for 24 weeks—A prospective randomized phase III study.
 
Marianne Sinn
Honoraria - Celgene; LEO Pharma; Roche Pharma AG
Travel, Accommodations, Expenses - Bayer
 
Torsten Liersch
No Relationships to Disclose
 
Klaus Gellert
No Relationships to Disclose
 
Helmut Messmann
No Relationships to Disclose
 
Wolf O. Bechstein
No Relationships to Disclose
 
Dirk Waldschmidt
No Relationships to Disclose
 
Lutz Jacobasch
No Relationships to Disclose
 
Martin Wilhelm
No Relationships to Disclose
 
Bettina M Rau
No Relationships to Disclose
 
Robert Grützmann
No Relationships to Disclose
 
Arndt Weinmann
No Relationships to Disclose
 
Georg Maschmeyer
No Relationships to Disclose
 
Uwe Pelzer
Honoraria - Bayer; Braun Travacare; Celgene; Roche Pharma AG
 
Jens Stieler
Honoraria - Amgen; Roche Pharma AG
Consulting or Advisory Role - Amgen; Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Roche Pharma AG
 
Jana Kaethe Striefler
No Relationships to Disclose
 
B. Michael Ghadimi
No Relationships to Disclose
 
Marcus Bahra
No Relationships to Disclose
 
Helmut Oettle
No Relationships to Disclose
 
Bernd Dörken
No Relationships to Disclose
 
Hanno Riess
Consulting or Advisory Role - Bayer; Celgene; GlaxoSmithKline; Roche Pharma AG
Speakers' Bureau - Bayer; Celgene; GlaxoSmithKline; Roche Pharma AG